tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Moderna narrows FY25 revenue view to $1.6B-$2B from $1.5B-$2.2B

Consensus is $1.88B. Cost of sales for 2025 is expected to be approximately $0.8B-$0.9B, lowered from $1.2B. The company continues to expect its full-year tax expense to be negligible. Capital expenditures for 2025 are expected to be approximately $0.3B.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1